Skip to main content

Peer Review reports

From: A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam

Original Submission
29 Sep 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Oct 2023 Reviewed Reviewer Report - Christos Chouaïd
3 Dec 2023 Reviewed Reviewer Report
29 Dec 2023 Author responded Author comments - Thi Thai Hoa Nguyen
Resubmission - Version 3
29 Dec 2023 Submitted Manuscript version 3
31 Dec 2023 Author responded Author comments - Thi Thai Hoa Nguyen
Resubmission - Version 4
31 Dec 2023 Submitted Manuscript version 4
15 Jan 2024 Reviewed Reviewer Report
16 Jan 2024 Reviewed Reviewer Report - Christos Chouaïd
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
17 Jan 2024 Editorially accepted
5 Feb 2024 Article published 10.1186/s12885-024-11891-w

You can find further information about peer review here.

Back to article page